Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathology of malignant lymphomas.

N L Harris1

  • 1Massachusetts General Hospital, Harvard Medical School, Boston.

Current Opinion in Oncology
|October 1, 1991
PubMed
Summary

Understanding malignant lymphomas involves studying neoplastic lymphoid cells and genetic abnormalities. Recent advances refine classifications of B-cell and T-cell lymphomas, aiding diagnosis and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal eosinophils: multifaceted roles in tissue homeostasis and disease.

Seminars in immunopathology·2021
Same author

Attribution of net carbon change by disturbance type across forest lands of the conterminous United States.

Carbon balance and management·2016
Same author

Interactions between the intestinal microbiome and helminth parasites.

Parasite immunology·2015
Same author

Mucosal immune responses following intestinal nematode infection.

Parasite immunology·2014
Same author

Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation.

Allergy·2014
Same author

Understanding the role of antibodies in murine infections with Heligmosomoides (polygyrus) bakeri: 35 years ago, now and 35 years ahead.

Parasite immunology·2013

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Malignant lymphomas are complex cancers of lymphoid cells.
  • Understanding their relationship to normal lymphocyte differentiation and genetic abnormalities is crucial for effective treatment.

Purpose of the Study:

  • To define clinically important lymphoma entities for targeted treatment strategies.
  • To explore new avenues for lymphoma treatment and prevention.
  • To clarify the origins and genetic underpinnings of malignant lymphomas.

Main Methods:

  • Investigating neoplastic lymphoid cells in relation to T- and B-lymphocyte differentiation.
  • Analyzing genetic abnormalities associated with malignant transformation.
  • Utilizing molecular genetics and molecular cytogenetics, including chromosomal translocation studies.

Main Results:

  • Recent advances include subclassification of low-grade B-cell lymphomas (e.g., intermediate lymphocytic lymphoma, extranodal lymphomas of mucosa-associated lymphoid tissue).
  • Classification of T-cell lymphomas has improved, along with defining Hodgkin's disease and its relation to anaplastic large cell lymphoma.
  • New techniques for characterizing lymphoid cells in paraffin-embedded tissues have been developed.

Conclusions:

  • Despite ongoing research, the relationship between lymphoma cells and the normal immune system remains incompletely understood.
  • Molecular genetics and cytogenetics are beginning to elucidate neoplastic transformation, but further research is needed.
  • Recent classifications and techniques represent significant progress in understanding and managing malignant lymphomas.

Related Experiment Videos